
Regeneron Pharmaceuticals, Inc.
REGNHealthcare|Biotechnology|US
$904.35
+1.45 (+0.16%)
DCF Value
$2028.80
Tangible Book / Share
$316.45
Graham Number
$592.50
Cash / Share
$91.46
Financials
Financial Snapshot
Market Cap
$93.54B
Enterprise Value
$92.59B
Revenue (TTM)
$16.90B
Net Income (TTM)
$4.82B
Cash & Investments
$9.30B
Net Cash
$6.59B
Free Cash Flow (TTM)
$3.59B
Operating CF (TTM)
$4.61B
Debt/Equity
0.08
Cash Runway & Burn Rate
Company is cash-flow positive.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $1.04B | $1.41B | $2.81B | $3.21B | $3.59B | $5.69B | $7.74B | $10.84B | $9.01B | $8.61B | $9.30B | |
| Operating Cash Flow | $1.49B | $1.31B | $2.20B | $2.43B | $2.62B | $7.08B | $5.01B | $4.59B | $4.42B | $4.98B | $4.61B | |
| Free Cash Flow | $974.0M | $1.03B | $1.81B | $2.00B | $2.00B | $6.53B | $4.42B | $3.67B | $3.66B | $4.08B | $3.59B | |
| Capital Expenditure | -$511.9M | -$272.6M | -$383.1M | -$429.6M | -$614.6M | -$551.9M | -$590.1M | -$926.4M | -$755.9M | -$898.4M | -$1.02B | |
| Financing Cash Flow | -$700.4M | -$24.4M | -$77.1M | -$252.1M | -$1.97B | -$1.01B | -$1.01B | -$1.79B | -$2.20B | -$3.72B | -$4.22B |
R&D Spending
R&D (TTM)
$6.72B
R&D Intensity
39.8%
R&D Growth vs Prior
+14.9%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.86B | $5.87B | $6.71B | $6.56B | $8.50B | $16.07B | $12.17B | $13.12B | $14.20B | $14.34B | $16.90B | |
| R&D Expense | $1.95B | $1.93B | $2.04B | $2.24B | $2.50B | $2.62B | $3.06B | $3.99B | $5.23B | $5.85B | $6.72B | |
| R&D % of Revenue | 40.1% | 32.9% | 30.4% | 34.2% | 29.4% | 16.3% | 25.1% | 30.4% | 36.8% | 40.8% | 39.8% | |
| SG&A | $1.18B | $1.32B | $1.56B | $1.34B | $1.35B | $1.82B | $2.12B | $2.54B | $2.95B | $2.70B | $2.76B |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.86B | $5.87B | $6.71B | $6.56B | $8.50B | $16.07B | $12.17B | $13.12B | $14.20B | $14.34B | $16.90B | |
| Cost of Revenue | $404.4M | $542.5M | $582.3M | $975.4M | $1.36B | $2.72B | $1.71B | $2.24B | $1.97B | $2.10B | $2.40B | |
| Gross Profit | $4.46B | $5.33B | $6.13B | $5.58B | $7.14B | $13.35B | $10.47B | $10.87B | $12.23B | $12.24B | $14.49B | |
| R&D | $1.95B | $1.93B | $2.04B | $2.24B | $2.50B | $2.62B | $3.06B | $3.99B | $5.23B | $5.85B | $6.72B | |
| SG&A | $1.18B | $1.32B | $1.56B | $1.34B | $1.35B | $1.82B | $2.12B | $2.54B | $2.95B | $2.70B | $2.76B | |
| Operating Income | $1.33B | $2.08B | $2.53B | $2.21B | $3.58B | $8.95B | $5.39B | $4.35B | $3.99B | $3.58B | $4.99B | |
| Interest Expense | $7.2M | $25.1M | $28.2M | $30.2M | $56.9M | $57.3M | $59.4M | $73.0M | $55.2M | $43.8M | $46.7M | |
| Pretax Income | $1.33B | $2.08B | $2.55B | $2.43B | $3.81B | $9.33B | $4.86B | $4.20B | $4.78B | $5.23B | $5.69B | |
| Net Income | $895.5M | $1.20B | $2.44B | $2.12B | $3.51B | $8.08B | $4.34B | $3.95B | $4.41B | $4.50B | $4.82B | |
| EPS (Diluted) | 7.70 | 10.34 | 21.29 | 18.46 | 30.52 | 71.97 | 38.22 | 34.77 | 38.34 | 41.48 | 45.26 | |
| EBITDA | $1.44B | $2.25B | $2.73B | $2.67B | $4.10B | $9.67B | $5.26B | $4.69B | $5.32B | $5.82B | $6.25B | |
| Shares Out. (M) | 116.30 | 115.91 | 114.80 | 114.60 | 115.10 | 112.20 | 113.50 | 113.70 | 115.10 | 108.60 | 105.60 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $535.2M | $812.7M | $1.47B | $1.62B | $2.19B | $2.89B | $3.11B | $2.73B | $2.49B | $3.12B | $3.66B | |
| Short-Term Investments | $503.5M | $596.8M | $1.34B | $1.60B | $1.39B | $2.81B | $4.64B | $8.11B | $6.52B | $5.49B | $5.64B | |
| Total Current Assets | $3.91B | $5.60B | $7.96B | $7.69B | $9.78B | $14.01B | $15.88B | $19.48B | $18.66B | $18.02B | $20.80B | |
| Total Assets | $6.97B | $8.76B | $11.73B | $14.81B | $17.16B | $25.43B | $29.21B | $33.08B | $37.76B | $40.56B | $44.41B | |
| Total Current Liabilities | $1.24B | $1.14B | $1.44B | $2.10B | $2.70B | $3.93B | $3.14B | $3.42B | $3.94B | $4.37B | $6.20B | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | $1.99B | $1.99B | |
| Total Liabilities | $2.52B | $2.62B | $2.98B | $3.72B | $6.14B | $6.67B | $6.55B | $7.11B | $8.41B | $9.30B | $10.91B | |
| Stockholders' Equity | $4.45B | $6.14B | $8.76B | $11.09B | $11.03B | $18.77B | $22.66B | $25.97B | $29.35B | $31.26B | $33.50B | |
| Retained Earnings | $1.75B | $2.95B | $5.25B | $7.38B | $10.89B | $18.97B | $23.31B | $27.26B | $31.67B | $35.80B | $39.47B |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.49B | $1.31B | $2.20B | $2.43B | $2.62B | $7.08B | $5.01B | $4.59B | $4.42B | $4.98B | $4.61B | |
| Capital Expenditure | -$511.9M | -$272.6M | -$383.1M | -$429.6M | -$614.6M | -$551.9M | -$590.1M | -$926.4M | -$755.9M | -$898.4M | -$1.02B | |
| Free Cash Flow | $974.0M | $1.03B | $1.81B | $2.00B | $2.00B | $6.53B | $4.42B | $3.67B | $3.66B | $4.08B | $3.59B | |
| Investing Cash Flow | -$1.05B | -$1.01B | -$1.46B | -$2.03B | -$70.6M | -$5.38B | -$3.78B | -$3.19B | -$2.47B | -$629.1M | -$589.4M | |
| Financing Cash Flow | -$700.4M | -$24.4M | -$77.1M | -$252.1M | -$1.97B | -$1.01B | -$1.01B | -$1.79B | -$2.20B | -$3.72B | -$4.22B | |
| Issuance of Stock | $126.7M | $240.2M | $114.5M | $211.8M | $2.58B | $1.67B | $1.52B | $1.15B | $1.47B | $635.9M | $1.02B | |
| Repurchase of Stock | -$143.2M | -$301.7M | -$191.6M | -$463.9M | -$6.53B | -$2.68B | -$2.53B | -$2.23B | -$3.63B | -$3.97B | -$3.04B | |
| Net Debt Issuance | -$40.6M | $37.1M | $0.00 | $0.00 | $1.98B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $559.9M | $507.3M | $427.4M | $464.3M | $432.0M | $601.7M | $725.0M | $885.0M | $982.8M | $993.7M | $1.01B | |
| Net Change in Cash | -$273.9M | $277.5M | $655.0M | $150.1M | $577.0M | $690.8M | $221.3M | -$381.6M | -$248.8M | $634.7M | -$200.2M |
Dilution Tracker
Shares Outstanding
103M
5-Year Share Growth
-5.6%
Stock Issuance (TTM)
$1.02B
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 116.30 | 115.91 | 114.80 | 114.60 | 115.10 | 112.20 | 113.50 | 113.70 | 115.10 | 108.60 | 105.60 | |
| Change vs Prior % | — | -0.3% | -1.0% | -0.2% | 0.4% | -2.5% | 1.2% | 0.2% | 1.2% | -5.6% | -2.8% | |
| Stock Issuance | $126.7M | $240.2M | $114.5M | $211.8M | $2.58B | $1.67B | $1.52B | $1.15B | $1.47B | $635.9M | $1.02B | |
| Stock Repurchase | -$143.2M | -$301.7M | -$191.6M | -$463.9M | -$6.53B | -$2.68B | -$2.53B | -$2.23B | -$3.63B | -$3.97B | -$3.04B | |
| Stock Based Comp. | $559.9M | $507.3M | $427.4M | $464.3M | $432.0M | $601.7M | $725.0M | $885.0M | $982.8M | $993.7M | $1.01B |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 91.7% | 90.8% | 91.3% | 85.1% | 84.0% | 83.1% | 86.0% | 82.9% | 86.1% | 85.4% | 85.8% | |
| Operating Margin % | 27.4% | 35.4% | 37.8% | 33.7% | 42.1% | 55.7% | 44.2% | 33.2% | 28.1% | 24.9% | 29.5% | |
| Net Margin % | 18.4% | 20.4% | 36.4% | 32.3% | 41.3% | 50.2% | 35.6% | 30.1% | 31.1% | 31.4% | 28.5% | |
| EBITDA Margin % | 29.7% | 38.3% | 40.7% | 40.7% | 48.3% | 60.2% | 43.2% | 35.8% | 37.4% | 40.6% | 37.0% | |
| FCF Margin % | 20.0% | 17.6% | 27.0% | 30.5% | 23.6% | 40.6% | 36.3% | 28.0% | 25.8% | 28.4% | 21.2% | |
| ROE % | 20.1% | 19.5% | 27.9% | 19.1% | 31.9% | 43.0% | 19.1% | 15.2% | 15.0% | 14.4% | 15.1% | |
| ROA % | 12.8% | 13.7% | 20.8% | 14.3% | 20.5% | 31.7% | 14.9% | 12.0% | 11.7% | 11.1% | 10.8% | |
| ROIC % | 13.6% | 13.5% | 20.6% | 15.1% | 22.8% | 34.9% | 18.4% | 13.8% | 10.9% | 8.5% | 10.9% | |
| R&D / Revenue % | 40.1% | 32.9% | 30.4% | 34.2% | 29.4% | 16.3% | 25.1% | 30.4% | 36.8% | 40.8% | 39.8% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.4% | 20.8% | 14.3% | -2.3% | 29.6% | 89.1% | -24.3% | 7.8% | 8.3% | 1.0% | |
| Gross Profit | 22.5% | 19.6% | 15.0% | -8.9% | 27.9% | 86.9% | -21.6% | 3.9% | 12.5% | 0.1% | |
| Operating Income | 6.3% | 56.3% | 21.9% | -12.8% | 61.9% | 150.1% | -39.8% | -19.3% | -8.2% | -10.3% | |
| Net Income | 40.8% | 33.8% | 104.0% | -13.4% | 66.0% | 129.9% | -46.3% | -8.9% | 11.6% | 2.1% | |
| EPS (Diluted) | 39.5% | 34.3% | 105.9% | -13.3% | 65.3% | 135.8% | -46.9% | -9.0% | 10.3% | 8.2% | |
| Operating Cash Flow | 11.7% | -12.0% | 67.9% | 10.7% | 7.7% | 170.5% | -29.2% | -8.4% | -3.8% | 12.6% | |
| Free Cash Flow | 49.2% | 6.2% | 75.2% | 10.4% | 0.2% | 225.9% | -32.2% | -17.1% | -0.1% | 11.3% | |
| R&D Expense | 26.0% | -0.9% | 5.6% | 9.9% | 11.6% | 4.9% | 16.6% | 30.5% | 31.3% | 11.8% | |
| SG&A Expense | 40.4% | 12.1% | 17.9% | -13.8% | 0.3% | 35.6% | 15.9% | 20.0% | 16.3% | -8.6% | |
| Total Assets | 24.3% | 25.7% | 33.9% | 26.2% | 15.9% | 48.2% | 14.9% | 13.2% | 14.1% | 7.4% | |
| Book Value / Share | 20.7% | 38.5% | 43.9% | 33.1% | 0.9% | 73.3% | 19.2% | 15.0% | 11.8% | 9.8% | |
| Debt | 28.1% | 46.2% | 0.7% | 0.8% | 277.6% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| Diluted Shares | 0.9% | -0.3% | -1.0% | -0.2% | 0.4% | -2.5% | 1.2% | 0.2% | 1.2% | -5.6% |
Valuation
P/E (TTM)19.26
10Y Low / Med / High8.27 / 17.92 / 42.93
P/S5.54
10Y Low / Med / High4.15 / 6.35 / 8.78
P/B2.75
10Y Low / Med / High2.58 / 3.70 / 9.59
EV/EBITDA14.82
10Y Low / Med / High6.88 / 15.02 / 29.56
EV/Revenue5.48
10Y Low / Med / High4.14 / 6.28 / 8.77
P/FCF26.07
10Y Low / Med / High10.22 / 23.66 / 43.81
Intrinsic Value Models (per share)
DCF Value
$2028.80
Tangible Book / Share
$316.45
Net Current Assets / Share
$95.60
Graham Number
$592.50
Graham Net-Net
$54.33
Cash / Share
$91.46
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | 42.93 | 33.36 | 17.54 | 19.37 | 14.80 | 8.27 | 17.81 | 23.71 | 17.42 | 17.92 | 19.26 | |
| P/S Ratio | 8.78 | 7.42 | 6.39 | 6.25 | 6.12 | 4.15 | 6.35 | 7.14 | 5.41 | 5.63 | 5.54 | |
| P/B Ratio | 9.59 | 7.09 | 4.90 | 3.70 | 4.71 | 3.56 | 3.41 | 3.61 | 2.62 | 2.58 | 2.75 | |
| EV/EBITDA | 29.56 | 19.33 | 15.43 | 15.02 | 12.79 | 6.88 | 14.61 | 19.96 | 14.49 | 13.81 | 14.82 | |
| EV/Revenue | 8.77 | 7.40 | 6.28 | 6.11 | 6.18 | 4.14 | 6.31 | 7.14 | 5.43 | 5.60 | 5.48 |
Analyst Estimates & Quality
Altman Z-Score
7.59
Safe
Piotroski F-Score
6
Moderate
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $18.75B | $20.10B | $21.74B |
| Net Income | $7.39B | $7.54B | $8.34B |
| EPS | $67.55 | $70.32 | $77.93 |
| # Analysts (EPS) | 15 | 10 | 8 |
Dividends
Dividend/Share (TTM)
$3.70
Dividend Yield
0.41%
Frequency
Quarterly
Next Payment
Dec 3, 2026
Recent Payments
| Ex-Date | Pay Date | Amount | Frequency |
|---|---|---|---|
| Nov 20, 2026 | Dec 3, 2026 | $0.94 | Quarterly |
| Aug 18, 2026 | Aug 31, 2026 | $0.94 | Quarterly |
| May 20, 2026 | Jun 4, 2026 | $0.94 | Quarterly |
| Feb 20, 2026 | Mar 5, 2026 | $0.94 | Quarterly |
| Nov 20, 2025 | Dec 5, 2025 | $0.88 | Quarterly |
| Aug 18, 2025 | Sep 3, 2025 | $0.88 | Quarterly |
| May 20, 2025 | Jun 6, 2025 | $0.88 | Quarterly |
| Feb 20, 2025 | Mar 20, 2025 | $0.88 | Quarterly |
Revenue Segments
By Product
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Product | $5.57B | $12.12B | $6.89B | $7.08B | $7.63B | $6.31B |
| Product and Service, Other | — | $281.2M | $365.1M | $536.1M | $515.0M | $702.6M |
| Collaboration Revenue | — | — | $2.06B | $5.50B | $6.06B | $7.33B |
By Geography
| Segment | 2025 |
|---|---|
| UNITED STATES | $4.38B |
| Rest Of World | $507.5M |